139 related articles for article (PubMed ID: 35227227)
1. Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma.
Shao YY; Kuo HY; Jeng YM; Wu YM; Wang HP; Hsu C; Hsu CH; Hsu HC; Cheng AL; Lin ZZ
BMC Cancer; 2022 Feb; 22(1):219. PubMed ID: 35227227
[TBL] [Abstract][Full Text] [Related]
2. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
4. Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.
Chen Z; Pu L; Gao W; Zhang L; Han G; Zhu Q; Li X; Wu J; Wang X
Oncotarget; 2017 Apr; 8(17):28959-28970. PubMed ID: 28415824
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
8. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
[TBL] [Abstract][Full Text] [Related]
9. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
11. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
13. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L
BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations.
Miyata T; Yamashita YI; Yamao T; Umezaki N; Tsukamoto M; Kitano Y; Yamamura K; Arima K; Kaida T; Nakagawa S; Imai K; Hashimoto D; Chikamoto A; Ishiko T; Baba H
Int J Clin Oncol; 2017 Jun; 22(3):526-532. PubMed ID: 28205002
[TBL] [Abstract][Full Text] [Related]
15. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
[TBL] [Abstract][Full Text] [Related]
16. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
18. Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.
Isidro RA; Abukhiran I; Dunseth CD; Gosse MD; Humble RM; Pelletier DJ; Varshney N; Bellizzi AM; Hornick JL
Am J Surg Pathol; 2023 Apr; 47(4):440-452. PubMed ID: 36730833
[TBL] [Abstract][Full Text] [Related]
19. Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent.
Takahashi T; Kawaji H; Murakawa Y; Hayashizaki Y; Murakami T; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
Eur J Surg Oncol; 2021 Feb; 47(2):394-400. PubMed ID: 32878723
[TBL] [Abstract][Full Text] [Related]
20. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
